Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase

被引:84
|
作者
Burke, DH
Scates, L
Andrews, K
Gold, L
机构
[1] UNIV COLORADO, DEPT MOL CELLULAR & DEV BIOL, BOULDER, CO 80309 USA
[2] NEXSTAR PHARMACEUT INC, BOULDER, CO 80301 USA
关键词
reverse transcriptase; RNA-protein interactions; SELEX; RNA pseudoknots; nucleic acid structure;
D O I
10.1006/jmbi.1996.0667
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The reverse transcriptase (RT) of the human immunodeficiency virus (HIV) is a proven target for therapeutic intervention of HIV infections. We have found several new RNA inhibitors of HIV-1 RT that differ significantly from the pseudoknot ligands found previously, along with a wide variety of pseudoknot variants. One pseudoknot variant and three novel ligands were studied in more detail. Each specifically inhibits DNA polymerization by HIV RT (half-maximal inhibition at 0.3 to 20 nM inhibitor), but not that of RTs derived from MMLV or AMV. The minimal binding element of each isolate was determined by deletion analysis and by gel electrophoresis of protein-bound, partially alkaline-hydrolyzed RNA. Truncations of three of the isolates bound nearly as well as (or better than) the parental sequences, while most deletions in the fourth caused substantial disruption of binding. The truncated versions of two isolates were subjected to six rounds of secondary SELEX after resynthesizing them mutagenically. Patterns of conserved and covarying nucleotides yielded structural models consistent with 5' and 3' boundary determinations for these molecules. Among the four isolates studied in detail, the first is confirmed as being a pseudoknot, albeit with substantial structural differences as compared to the canonical pseudoknots identified previously. The second forms a stem-loop structure with additional flanking sequences required for binding. Tentative structural models for the other two isolates are presented. The minimal fully active truncations of each of these four isolates compete with each other and with a classical RNA pseudoknot for binding to HIV RT, suggesting that they all recognize the same or overlapping sites on the protein, in spite of their apparently dissimilar structures. We model their interactions with RT as mimicking the 40 to 45 degree bend in dsDNA co-crystallized with RT. (C) 1996 Academic Press Limited
引用
收藏
页码:650 / 666
页数:17
相关论文
共 50 条
  • [31] DESIGN AND SYNTHESIS OF NOVEL INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE
    MARUENDA, H
    JOHNSON, F
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) : 2145 - 2151
  • [32] Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors
    Patel, M
    McHugh, RJ
    Cordova, BC
    Klabe, RM
    Bacheler, LT
    Erickson-Viitanen, S
    Rodgers, JD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1943 - 1945
  • [33] SYNTHESIS AND EVALUATION OF NOVEL INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE
    LYLE, TA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 27 - ORGN
  • [34] Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins
    Cherry, E
    Liang, C
    Rong, LW
    Quan, YD
    Inouye, P
    Li, XG
    Morin, N
    Kotler, N
    Wainberg, MA
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 284 (01) : 43 - 56
  • [35] Investigating the "steric gate" of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by targeted insertion of unnatural amino acids
    Klarmann, George J.
    Eisenhauer, Brian M.
    Zhang, Yi
    Gotte, Matthias
    Pata, Janice D.
    Chatterjee, Deb K.
    Hecht, Sidney M.
    Le Grice, Stuart F. J.
    BIOCHEMISTRY, 2007, 46 (08) : 2118 - 2126
  • [36] MUTATIONAL ANALYSIS OF THE FINGERS AND PALM SUBDOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE
    BOYER, PL
    FERRIS, AL
    CLARK, P
    WHITMER, J
    FRANK, P
    TANTILLO, C
    ARNOLD, E
    HUGHES, SH
    JOURNAL OF MOLECULAR BIOLOGY, 1994, 243 (03) : 472 - 483
  • [37] ENGINEERING OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE GENE TO PREVENT DIMERIZATION OF THE EXPRESSED CHIMERIC PROTEIN - PURIFICATION AND CHARACTERIZATION OF A MONOMERIC HIV-1 REVERSE-TRANSCRIPTASE
    SHARMA, SK
    BASU, A
    FAN, NS
    EVANS, DB
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 1994, 19 : 155 - 167
  • [38] Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase
    LeGrice, SFJ
    Cameron, CE
    Benkovic, SJ
    DNA REPLICATION, 1995, 262 : 130 - 144
  • [39] Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription
    Hooker, CW
    Lott, WB
    Harrich, D
    JOURNAL OF VIROLOGY, 2001, 75 (07) : 3095 - 3104
  • [40] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES OF NOVEL NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS
    NOTTET, HSLM
    OTEMAN, MHT
    VISSER, MR
    VERHOEF, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (02) : 366 - 368